Lee Ainslie’s CVS Health CVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-9,472
Closed -$680K 211
2026
Q1
$680K Buy
+9,472
New +$730K 0.01% 193
2023
Q4
Sell
-22,676
Closed -$1.58M 380
2023
Q3
$1.58M Buy
22,676
+6,916
+44% +$490K 0.04% 90
2023
Q2
$1.09M Buy
15,760
+8,842
+128% +$629K 0.02% 156
2023
Q1
$514K Buy
6,918
+4,345
+169% +$364K 0.01% 251
2022
Q4
$240K Buy
+2,573
New +$248K 0.01% 346
2021
Q2
Sell
-11,556
Closed -$869K 708
2021
Q1
$869K Buy
+11,556
New +$842K 0.01% 286
2020
Q4
Sell
-13,166
Closed -$769K 699
2020
Q3
$769K Buy
13,166
+12,902
+4,887% +$803K 0.01% 342
2020
Q2
$17K Buy
+264
New +$16.6K ﹤0.01% 554

Other funds holding CVS

Lee Ainslie's CVS Position: Q2 2026 in Review

Lee Ainslie sold out of CVS Health (CVS) in Q2 2026, closing a stake of 9,472 shares — an estimated $680K sold.

Lee Ainslie first reported a position in CVS in Q2 2020 and held it in 8 quarters. The position peaked at $1.58M in Q3 2023. 2,059 funds tracked by Wall St. Rank hold CVS as of Q2 2026.

  • Lee Ainslie reported no remaining CVS Health position as of Q2 2026 after selling out during the quarter.
  • Lee Ainslie sold 9,472 CVS Health shares in Q2 2026, an estimated $680K.
  • Lee Ainslie first reported a position in CVS Health in Q2 2020 and held it in 8 quarters.
  • Lee Ainslie's CVS Health position peaked at $1.58M in Q3 2023.
  • 2,059 funds tracked by Wall St. Rank held CVS Health as of Q2 2026.

Based on Maverick Capital's 13F filing for Q2 2026, filed 14 Aug 2026.